Last year AstraZeneca sold the marketing rights to its over-the-counter (OTC) version of Nexium to Pfizer Inc. due to declining revenues, for $250 million. AstraZeneca will receive royalty payments from Pfizer for the OTC version, as well as...
The Dangers of Proton Pump Inhibitors
Millions of people in the U.S. take proton pump inhibitors (PPIs). Popular brands include Prilosec, Nexium and Prevacid. These drugs treat gastroesophageal reflux disease (GERD), in which the stomach acid flows back up into the esophagus. This...
Pfizer Settles for $491 Million for Rapamune False Claims Act
Pfizer settled a civil lawsuit which alleged that Wyeth, acquired by Pfizer in 2009, engaged in illegal off-label marketing of the organ transplant drug Rapamune, but at a hefty price. In addition, Wyeth will plead guilty to a misdemeanor...